Alcon

$63.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.96 (+1.53%) As of 1:01 PM EST today

Why Robinhood?

You can buy or sell Alcon and other stocks, options, and ETFs commission-free!

About ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland. The listed name for ALC is Alcon Inc. Ordinary Shares.

CEO
David J. Endicott
Employees
22,142
Headquarters
Fribourg, Fribourg
Founded
1945
Market Cap
31.10B
Price-Earnings Ratio
Dividend Yield
Average Volume
980.41K
High Today
$63.65
Low Today
$62.90
Open Price
$63.17
Volume
323.02K
52 Week High
$68.11
52 Week Low
$39.37

Collections

ALC Earnings

-$0.21
$0.02
$0.25
$0.48
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Available Feb 23, After Hours

You May Also Like